Ultra Bionics, founded by Synchron co-founder Nick Opie, applies the same endovascular delivery approach that built Synchron's stent-electrode BCI to a stimulation rather than recording problem, targeting deep brain structures via blood vessels instead of open-brain DBS surgery. Backing from the University of Melbourne ecosystem and collaboration with the Florey Institute places it within a track record of successful Melbourne braintech translation, though it remains in large-animal validation ahead of first-in-human trials.